Authored By: Sarah
21 Feb 2025

Point Of Care (POC) HIV Testing Market Analysis 2024-2028

The point of care (Poc) hiv testing market is projected to grow by USD 329.8 million between 2023 and 2028, expanding at a CAGR of 3.2%. The market is being driven by the rising prevalence of HIV/AIDS, growing awareness programs for HIV testing, and the need for rapid and accessible diagnostic solutions. The demand for POC HIV testing devices is increasing, particularly in regions with limited healthcare infrastructure, as these devices provide quick results and ease of use.

For more details about the industry, get the PDF sample report for free

Market Segmentation

By Product

POC HIV testing equipment
POC HIV testing reagents

By End-User

Diagnostic labs
Hospitals and clinics
Others

By Geography

North America
- US
Europe
- Germany
- UK
- France
Asia
- China
Rest of World (ROW)

Segment Insights

By Product

The POC HIV testing equipment segment is expected to experience significant growth during the forecast period. This segment includes:

Rapid HIV test kits
POC HIV viral load testing systems
POC CD4 count devices

These devices enable early diagnosis, swift treatment, and enhanced patient outcomes. UNAIDS reports that early detection and intervention significantly reduce HIV-related mortality and new infections. Additionally, biosensors, nanotechnology, and miniaturized devices are improving the accessibility and affordability of POC HIV testing.

Market Dynamics

Drivers

Increasing prevalence of HIV/AIDS worldwide
- The growing number of new infections and high-risk populations is a key market driver.
- Home-based HIV testing kits are gaining popularity due to their convenience and ease of use.
- HIV can be transmitted through blood transfusions and donations, making diagnostic testing crucial.

Trends

Rise in awareness programs for HIV testing
- Home-based and institutional HIV testing kits are being widely adopted.
- Organizations like UNAIDS emphasize pre- and post-test counseling as part of standard testing procedures.
- The industry is seeing the adoption of visual assays, rapid antigen tests, and telehealth solutions.

Challenges

Limited healthcare services in developing and underdeveloped nations
- The lack of resources and infrastructure hinders access to rapid HIV diagnostics.
- Cost barriers remain a challenge in developing regions.
- Solutions like portable PCR devices, telehealth, and remote monitoring are emerging to address these challenges.

Get more details by ordering the complete report